Idenix Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 68.0 | 67.4 | 64.7 |
| Cost of Goods Sold | 2.0 | 0.1 | -- |
| Gross Profit | 66.0 | 67.3 | -- |
| Gross Profit Margin | 97.1% | 99.9% | 0.0% |
| SG&A Expense | 149.0 | 149.6 | 118.2 |
| Depreciation & Amortization | 9.0 | 3.5 | 2.1 |
| Operating Income | (91.9) | (85.7) | (55.5) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 9.9 | 9.5 | 4.0 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (82.0) | (76.2) | (51.5) |
| Income Taxes | 0.5 | (1.1) | (0.7) |
| Net Income After Taxes | (82.5) | (75.1) | (50.8) |
| Continuing Operations | (82.5) | (75.1) | (50.8) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (82.5) | (75.1) | (50.8) |
| Total Net Income | (82.5) | (75.1) | (50.8) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.47) | (1.34) | (1.03) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
